How Did We Get a COVID-19 Vaccine in Less Than 1 Year?

Clin Cancer Res. 2021 Apr 15;27(8):2136-2138. doi: 10.1158/1078-0432.CCR-21-0079. Epub 2021 Feb 4.

Abstract

The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / therapeutic use*
  • Humans
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / immunology
  • Vaccination / methods
  • Vaccination / statistics & numerical data*

Substances

  • COVID-19 Vaccines